Dimethylsilane polyamines: Cytostatic compounds with potentials as anticancer drugs II. Uptake and potential cytotoxic mechanisms

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3765-3776

  Le Roch, N ^a   Douaud, F ^a   Havouis, R ^a   Delcros, J G ^a   Vaultier, M ^a   Moulinoux, J P ^a   Seiler, N ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b IRCAD   (France)

Author keywords

Analogues; Cells; Cytotoxicity; Polyamines; Uptake

Indexed keywords

ANTINEOPLASTIC AGENT; CALMODULIN; CYTOTOXIC AGENT; DIMETHYLSILANE; DNA; POLYAMINE; SILANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CALMODULIN; CELL AGGREGATION; CELL CYCLE; CELL DIVISION; CHO CELLS; CRICETINAE; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; LEUCINE; LEUKEMIA L1210; METHENAMINE; MICE; MICROSOMES, LIVER; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYAMINES; RATS; SILANES; SPERMIDINE; THYMIDINE;

EID: 0036875899     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Marton LJ and Pegg AE: Polyamines as targets for therapeutic interventions. Annu Rev Pharmacol Toxicol 35: 55-91, 1995.
2. Kramer DL: Polyamine inhibitors and analogs. In: Polyamines in Cancer. Basic Mechanisms and Clinical Approaches (Ed. Nishioka K), pp 151-189. Landes/Springer; New York, Austin, 1996.
3. Bergeron RJ, Feng Y, Weimar WR, McManis JS, Dimova H, Porter C, Raisler B and Phanstiel O: A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. J Med Chem 40: 1475-1494, 1997.
4. Le Roche N: Synthèse d' analogues siliciés de polyamines. Etude de leurs effets anticancéreux. PhD Thesis in Chemistry, University of Rennes 1, Rennes, France, 1997.
5. Douaud F, Le Roch N, Renault J, Havouis R, Vaultier M, Moulinoux JP and Seiler N: Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs. Anti-Cancer Drug Design 12: 621-633, 1997.
6. Seiler N, Delcros JG, Vaultier M, Le Roch N, Havouis R, Douaud F and Moulinoux JP: Bis(7-amino-4-azaheptyl)dimethylsilane: Inhibition of tumor cell growth in vitro and in vivo. Cancer Res 56: 5624-5630, 1996.
7. Seiler N, Douaud F, Havouis R, Le Roch N, Renault J, Vaultier M and Moulinoux JP: Dimethylsilane polyamines a new class of potential anticancer drugs: Effects on the growth of Lewis lung carcinoma in mice. Int J Oncol 11: 835-841, 1997.
8. Delcros JG, Vaultier M, LeRoch N, Havouis R, Moulinoux JP and Seiler N: Bis(7-amino-4-azaheptyl)dimethylsilane: a new tetramine with polyamine-like features. Effects on cell growth. Anti-Cancer Drug Design 12: 35-48, 1997.
9. Douaud F: Etude des effets aticancéreux d'analogues siliciés de polyamines. Ph.D. Thesis in Biology, University of Rennes 1, Rennes, France, 2000.
10. Mandel JL and Flintoff WF: Isolation of mutant mammalian cells altered in polyamine transport. J Cell Physiol 97: 335-344, 1978.
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
12. Crissman HA, Mullaney PF and Steinkamp JA: Methods and application of flow systems for analysis and sorting of mammalian cells. Meth Cell Biol 9: 195-221, 1975.
13. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
14. Dallner G, Bergstrand A and Nillson R: Heterogeneity of rough-surfaced liver microsomal membranes of adult, phenobarbital-treated, and newborn rats. J Cell Biol 38: 257-276, 1968.
15. Walters JD and Johnson JD: Inhibition of cyclic phosphodiesterase and calcineurin by spermine, a calcium independent calmodulin antagonist. Biochim Biophys Acta 957: 138-142, 1988.
16. Tsukada T, Furusako S, Maekawa S, Hibasami H and Nakashima K: Purification by affinity chromatography and characterization of porcine liver cytoplasmic polyamine oxidase. Int J Biochem 20: 695-702, 1988.
17. Guilbault GG, Kramer DN and Hackley E: A new substrate for fluorometric determination of oxidative enzymes. Anal. Chem 39: 271-276, 1967.
18. Bolkenius FN and Seiler N: Acetylderivatives as intermediates in polyamine catabolism. Int J Biochem 13: 287-292, 1981.
19. Winer BJ: Statistical Principles in Experimental Design. MacGraw Hill, New York, 1971.
20. Seiler N and Dezeure F: Polyamine transport in mammalian cells. Int J Biochem 22: 211-218, 1990.
21. Watanabe S, Kusama-Eguchi K, Kobayashi H and Igarashi K: Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem 266: 20803-20809, 1991.
22. He Y, Kashiwagi K, Fukuchi J, Terao K, Shirahata A and Igarashi K: Correlation between the inhibition of cell growth by accumulated polyamines and the decrease of magnesium and ATP. Eur J Biochem 217: 89-96, 1993.
23. Seiler N: Polyamine oxidase, properties and functions. In: Current Neurochemical and Pharmacological Aspects of Biogenic Amines (Progr Brain Res Vol. 106). (Eds. Yu P, Tipton KF and Boulton AA), pp 333-344, Elsevier. Amsterdam, 1995.
24. Cornish-Bowden A: Principles of Enzyme Kinetics, Butterworths, London, Boston, 1976.
25. Porter CW, Miller J and Bergeron RJ: Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res 44: 126-128, 1984.
26. Seiler N, Delcros JG and Moulinoux JP: Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 28: 843-861, 1996.
27. Porter CW, Ganis B, Libby PR and Bergeron RJ: Correlation between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res 51: 3715-3720, 1991.
28. Cullis PM, Green RE, Merson-Davies L and Travis N: Probing the mechanism of transport and compartmentalisation of polyamines in mammalian cells. Chem Biol 6: 717-729, 1999.
29. Mitchell JL, Choe CY and Judd GG: Feedback repression of ornithine decarboxylase synthesis mediated by antizyme. Biochem J 320: 755-760, 1996.
30. Suzuki T, He Y, Kashiwagi K, Murakami Y, Hayashi S and Igarashi K: Antizyme protects against abnormal accumulation and toxicity of polyamines in ornithine decarboxylase-overproducing cells. Proc Natl Acad Sci USA 91: 8930-8934, 1994.
31. Schuber F, Hong K, Düzgünez N and Papahadjopoulos D: Polyamines as modulators of membrane fusion: Aggregation and fusion of liposomes. Biochemistry 22: 6134-6140, 1983.
32. Rudkin BB, Mamont PS and Seiler. N: Decreased protein-synthetic activity is an early consequence of spermidine depletion in rat hepatoma tissue culture cells. Biochem J 217: 731-741, 1984.
33. La Porte DC, Wierman BM and Storm DR: Calcium-induced exposure of a hydrophobic surface on calmodulin. Biochemistry 19: 3814-3819, 1980.
34. Tanaka T, Ohmura T and Hidaka H: Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Mol Pharmacol 22: 403-407, 1982.
35. Rasmussen CD and Means A: Calmodulin, cell growth and gene expression. TINS 12: 433-438, 1989.
36. Klee CB, Crouch TH and Richman PG: Calmodulin. Annu Rev Biochem 49: 489-515, 1980.
37. Hait WN: Targeting calmodulin for the development of novel cancer chemotherapeutic agents. AntiCancer Drug Design 2: 139-149, 1987.
38. Bolkenius FN and Seiler N: New substrates of polyamine oxidase. Dealkylation of N-α,ω-diamines. Biol Chem Hoppe-Seyler 370: 525-531, 1989.
39. Bitoni AJ, Dumont JA, Bush TL, Stemerick DM, Edwards ML and McCann PP: Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase. J Biol Chem 265: 382-389, 1990.
40. Cohen SS: A Guide to the Polyamines. Oxford University Press, New York, Oxford, 1998.
41. Williams K: Modulation of ion channels: a new biology of polyamines. Cell Signalling 9: 1-13, 1997.